| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America AG Freifeld, EJ Bow, KA Sepkowitz, MJ Boeckh, JI Ito, CA Mullen, II Raad, ... Clinical infectious diseases 52 (4), e56-e93, 2011 | 4165 | 2011 |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. A Keech, RJ Simes, P Barter, J Best, R Scott, MR Taskinen, P Forder, ... Lancet (London, England) 366 (9500), 1849-1861, 2005 | 3552 | 2005 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2228 | 2019 |
| Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial AC Keech, P Mitchell, PA Summanen, J O'Day, TME Davis, MS Moffitt, ... The Lancet 370 (9600), 1687-1697, 2007 | 1370 | 2007 |
| Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening J Cox-Singh, TME Davis, KS Lee, SSG Shamsul, A Matusop, S Ratnam, ... Clinical infectious diseases 46 (2), 165-171, 2008 | 1272 | 2008 |
| An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in … GDH Turner, H Morrison, M Jones, TME Davis, S Looareesuwan, ID Buley, ... The American journal of pathology 145 (5), 1057, 1994 | 773 | 1994 |
| Common infections in diabetes: pathogenesis, management and relationship to glycaemic control AY Peleg, T Weerarathna, JS McCarthy, TME Davis Diabetes/metabolism research and reviews 23 (1), 3-13, 2007 | 750 | 2007 |
| Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand W Chaowagul, NJ White, DAB Dance, Y Wattanagoon, P Naigowit, ... Journal of Infectious Diseases 159 (5), 890-899, 1989 | 683 | 1989 |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial FIELD Study Investigators The Lancet 366 (9500), 1849-1861, 2005 | 548 | 2005 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 531* | 2021 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 530 | 2019 |
| Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study WA Davis, M Knuiman, P Kendall, V Grange, TME Davis Diabetes care 27 (3), 752-757, 2004 | 470 | 2004 |
| Clinical and Laboratory Features of Human Plasmodium knowlesi Infection C Daneshvar, TME Davis, J Cox-Singh, MZ Rafa'ee, SK Zakaria, ... Clinical Infectious Diseases 49 (6), 852-860, 2009 | 461 | 2009 |
| Piperaquine: a resurgent antimalarial drug TME Davis, TY Hung, IK Sim, HA Karunajeewa, KF Ilett Drugs 65, 75-87, 2005 | 376 | 2005 |
| Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study TME Davis, R Ting, JD Best, MW Donoghoe, PL Drury, DR Sullivan, ... Diabetologia 54, 280-290, 2011 | 371 | 2011 |
| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 344 | 2021 |
| Predictors of cognitive impairment and dementia in older people with diabetes DG Bruce, WA Davis, GP Casey, SE Starkstein, RM Clarnette, JK Foster, ... Diabetologia 51, 241-248, 2008 | 307* | 2008 |
| Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29 TME Davis, H Millns, IM Stratton, RR Holman, RC Turner, ... Archives of internal medicine 159 (10), 1097-1103, 1999 | 306 | 1999 |
| Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study PE Norman, WA Davis, DG Bruce, TME Davis Diabetes care 29 (3), 575-580, 2006 | 303 | 2006 |
| Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case … FM Sacks, MP Hermans, P Fioretto, P Valensi, T Davis, E Horton, ... Circulation 129 (9), 999-1008, 2014 | 302 | 2014 |
